
    
      Eligible patients will be treated according to the following scheme until the occurrence of
      maximum response, dose limiting toxicity or disease progression. Repeat cycles every 28 days
      for a maximum of 6 cycles and a minimum of 4.

        -  Bendamustine 60 mg/m2 i.v. days 1, 8, 15

        -  Dexamethasone 20 mg p.o. days 1,8 , 15, 22

        -  Thalidomide 100 mg daily p.o. days 1-28; initial dose of 50 mg/day, with an increment to
           100 mg after the first 15 days of treatment.
    
  